# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
- SEC Filing
Barrington Research analyst Alexander Paris maintains HealthEquity (NASDAQ:HQY) with a Outperform and maintains $105 price t...
Deutsche Bank analyst George Hill maintains HealthEquity (NASDAQ:HQY) with a Buy and raises the price target from $102 to $103.
JMP Securities analyst Constantine Davides reiterates HealthEquity (NASDAQ:HQY) with a Market Outperform and maintains $105 ...
RBC Capital analyst Sean Dodge reiterates HealthEquity (NASDAQ:HQY) with a Outperform and maintains $92 price target.
B of A Securities analyst Allen Lutz maintains HealthEquity (NASDAQ:HQY) with a Buy and lowers the price target from $105 to...